Articles tagged "Outcome"

2021 American Transplant Congress
How Long is the Wait Worthwhile: Cost-Effectiveness of Accepting a Kidney from a Donor with Apolipoprotein L1 High-Risk Genotype
K. Lentine¹, D. Brennan², M. Wang³, M. Schnitzler⁴, H. Xiao⁴, D. Axelrod⁵, J. Snyder⁶, K. Lentine⁴
¹Saint Louis University, St. Louis, MO, ²Johns Hopkins, Baltimore, MD, ³Washington Univ, Saint Louis, MO, ⁴Saint Louis Univ, Saint Louis, MO, ⁵Univ of Iowa, Iowa City, IA, ⁶SRTR, Minneapolis, MN
*Purpose: The Apolipoprotein L1 (APOL1) Long-Term Outcomes (APOLLO) study is underway to define the impact of kidney donor renal risk variants (RRVs) on the survival…
2021 American Transplant Congress
Impact of a Cmv Cell Mediated Immunity Based Protocol on Guiding Cmv Prophylaxis Following Pediatric Liver Transplantation – A Single Center Experience
G. Kalkan¹, S. Ball², L. McConnell², D. M. Desai³, A. Aqul³, P. K. Sue¹
¹Infectious Disease, University of Texas Southwestern Medical Center, Dallas, TX, ²Solid Organ Transplant Program, Children's Health, Dallas, TX, ³Solid Organ Transplant Program, University of Texas Southwestern Medical Center, Dallas, TX
*Purpose: Cytomegalovirus (CMV) is an important cause of morbidity following pediatric orthotopic liver transplantation (OLT), especially among high risk (HR) CMV D+/R- recipients. In 2019,…
2021 American Transplant Congress
The Relationship Between Health Literacy and Adverse Outcomes After Kidney Transplantation
E. Lorenz, T. Petterson, C. Schinstock, W. Sanchez, K. Yost
Mayo Clinic, Rochester, MN
*Purpose: Limited health literacy has been associated with a decreased likelihood of listing for transplant and an increased risk of waitlist mortality among kidney transplant…
2021 American Transplant Congress
Tacrolimus Shortage and the Rush to Convert: An Unexpected Burden on the System During the Covid-19 Pandemic?
N. Pilch, L. Johnson, M. Aldoughaim, N. Patel, F. Bartlett
Medical University of South Carolina, Charleston, SC
*Purpose: A national shortage of immediate release (IR) tacrolimus (FK) fully impacted our center in May 2020. The conversion process was immediately challenging during the…
2021 American Transplant Congress
Clinical Course and Outcomes in Solid Organ Transplant Recipients with Covid-19
R. C. Jackson¹, S. Challa², A. Halim¹, N. Kelly³, D. Maluf⁴, K. Shetty³, Z. Lominadze³
¹Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, ²Internal Medicine, University of Maryland Medical Center Midtown, Baltimore, MD, ³Program in Transplantation, Department of Medicine, University of Maryland Medical System, Baltimore, MD, ⁴Program in Transplantation, University of Maryland Medical System, Baltimore, MD
*Purpose: We characterized the outcomes of COVID-19 in our population of solid organ transplant recipients (SOTRs). Since these individuals are immunocompromised, with multiple comorbidities, we…
2021 American Transplant Congress
How Should Acute T-Cell Mediated Rejection of Kidney Transplants be Treated?
F. Aziz¹, S. Parajuli², N. Garg², M. Mohamed², A. Djamali², D. Mandelbrot²
¹University of Wisconsin, Madison, WI, ²University of Wisconsin, Verona, WI
*Purpose: Many guidelines suggest treating acute T-cell mediated rejection (TCMR) of kidney allografts that is Banff grade I with steroids alone and Banff grade II…
2021 American Transplant Congress
Initial Experience with Single-port Robotic-assisted Kidney Transplantation
M. Eltemamy, A. Aminsharifi, Y. Lin, Z. Schwen, M. Abou Zeinab, V. Krishnamurthi, D. Goldfarb, A. Wee, J. Kaouk
Cleveland Clinic, Cleveland, OH
*Purpose: Early experiences with multi-port robotic kidney transplantation have demonstrated a potential reduction in complications and improved convalescence while maintaining equivalent functional outcomes relative to…
2021 American Transplant Congress
Recent Trends and Outcomes of Liver Transplantation for Non-alcoholic Steatohepatitis versus Alcohol Liver Disease in the United States: Obesity Might be Protective
K. Okumura, I. Lee, H. Sogawa, G. Veillette, D. John, T. Diflo, R. Bodin, D. Wolf, S. Nishida
Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY
*Purpose: Nonalcoholic steatohepatitis (NASH) and alcohol liver disease (ALD) are rapidly growing indications for liver transplantation (LT). The recent trends and outcomes in NASH and…
2021 American Transplant Congress
Creating a Lung Transplant Program Search Tool Tailored to Patient Characteristics
W. T. McKinney¹, C. R. Schaffhausen¹, M. Bruin², S. Chu², J. Snyder³, M. Hertz⁴, M. Valapour⁵, B. Kasiske⁶, A. Israni¹
¹Hennepin Healthcare Research Institute, Minneapolis, MN, ²College of Design, University of Minnesota, Minneapolis, MN, ³Scientific Registry of Transplant Recipients, Minneapolis, MN, ⁴Medical School, University of Minnesota, Minneapolis, MN, ⁵Pulmonary Medicine, Cleveland Clinic, Cleveland, OH, ⁶Nephrology, Hennepin Healthcare, Minneapolis, MN
*Purpose: Criteria for selecting lung transplant candidates and donors vary between programs and evolve as clinical practice advances. This variation impacts patient outcomes and the…
2021 American Transplant Congress
Impact of Traveling for Transplant on Access to and Outcomes from Kidney and Liver Transplantation
K. Ross-Driscoll¹, R. Lynch¹, D. Axelrod², R. Patzer¹
¹Emory University, Atlanta, GA, ²University of Iowa, Ames, IA
*Purpose: Newly developed transplant referral regions (TRRs) can be used to understand how and why patients travel outside of their home transplant center to receive…